Data / Form D filings / Juneau Biosciences, LLC
Juneau Biosciences, LLC: Form D filings
Juneau Biosciences, LLC, a biotechnology company in Salt Lake City, UT, filed 6 Form D notices with the SEC between 2009 and 2013. The latest, on December 4, 2013, reports $25,000 sold of a $11.5 million offering to 1 investor.
Find out what Juneau Biosciences, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2749 East Parleys Way, Suite 210, Salt Lake City, UT, 84109
- Phone
- (888) 362-4496
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Utah
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1400105
The full lists. Form D filings in Utah: 660 rows, $33, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 4, 2013 | New notice | $11,500,000 | $25,000 | $11,475,000 | 1 | Nov 22, 2012 | sec.gov |
| Jun 13, 2012 | New notice | $10,000,000 | $500,000 | $9,500,000 | 1 | May 31, 2011 | sec.gov |
| Jul 20, 2011 | New notice | $4,000,000 | $1,000,000 | $3,000,000 | 1 | Jul 19, 2011 | sec.gov |
| Mar 1, 2011 | Amendment | $12,000,000 | $3,761,000 | $8,239,000 | 32 | May 21, 2010 | sec.gov |
| May 24, 2010 | New notice | $4,000,000 | $250,000 | $3,750,000 | 3 | May 21, 2010 | sec.gov |
| Mar 27, 2009 | New notice | $8,000,000 | $2,600,000 | $5,400,000 | 9 | Mar 23, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Eric L Robinson | Executive Officer, Director | |
| James L Marsh | Director | |
| Lesa L Nelson | Director | |
| Dinesh L Patel | Director | |
| Ken Ward | Executive Officer, Director | |
| Hans L Albertsen | Executive Officer |
Other biotechnology companies in Utah that filed recently
- Life Impact Partners 14 LLC offering · Nov 9, 2026
- Life Impact Partners 15 LLC offering · Nov 9, 2026
- Life Impact Partners 7 LLC offering · Nov 6, 2026
- Life Impact Partners 6 LLC offering · Nov 6, 2026
- Life Impact Partners 3 LLC offering · Nov 6, 2026
- Life Impact Partners 5 LLC offering · Nov 6, 2026
- Life Impact Partners 4 LLC offering · Nov 6, 2026
- Life Impact Partners 2 LLC offering · Nov 6, 2026
- Life Impact Partners 8 LLC offering · Nov 6, 2026
- Life Impact Partners 1 LLC offering · Oct 22, 2026
- 3Helix, Inc. $7.8 million · Sep 21, 2026
- Halia Therapeutics, Inc. $3.5 million · Aug 31, 2026
- Paterna BioSciences HoldCo Inc. $6.3 million · Aug 12, 2026
Every Form D from the week of Dec 2, 2013 · All recent filings in Utah · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Juneau Biosciences, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.